Bottom line
FDBIX vs IGIB: the short answer
FDBIX (Federated Hermes Corporate Bond Fund) and IGIB (iShares 5-10 Year Investment Grade Corporate Bond ETF) are both mutual funds.
But IGIB is far broader, holding 2,990 positions to 368 for FDBIX, so beyond the top names it adds exposure FDBIX doesn't have.
IGIB is cheaper at 0.04% vs 0.61% — a difference of $57 a year per $10,000 invested.
Over five years, IGIB returned +1.0% a year vs +0.4% for FDBIX.
Updated Nov 19, 2026
FDBIX vs IGIB side by side
| FDBIX | IGIB | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Federated Hermes | iShares |
| Category | Corporate Bond | Corporate Bond |
| Expense ratio | 0.61% | 0.04% |
| Annual cost per $10k | $61 | $4 |
| 10-yr cost on $10k (prospectus) | $918 | $51 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +7.2% | +9.6% |
| 5-yr return (annualized) | +0.4% | +1.0% |
| 10-yr return (annualized) | +3.7% | +3.4% |
| Best quarter | — | +10.3% |
| Worst quarter | — | −7.0% |
| Net assets (fund) | $972.9M | $18.2B |
| Number of holdings | 368 | 2,990 |
| Portfolio turnover | 12% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FDBIX and IGIB share none of their top holdings.
FDBIX top 10
- Federated Core Trust - High Yield Bond Portfolio — 14.67%
- Jpmorgan Chase & Co — 0.77%
- Nextera Energy Capital — 0.70%
- Dh Europe Finance II — 0.65%
- Wells Fargo & Company — 0.64%
- Anheuser-busch Inbev Wor — 0.59%
- Bank Of America Corp — 0.58%
- Allegion Plc — 0.56%
- Hca Inc — 0.55%
- Leidos Inc — 0.54%
IGIB top 10
- BlackRock Funds III — 11.07%
- Meta Platforms Inc — 0.23%
- Amazon.com Inc — 0.22%
- Anheuser-busch Co/inbev — 0.20%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Mars Inc — 0.19%
- Pfizer Investment Enter — 0.18%
- Jpmorgan Chase & Co — 0.18%
FAQ
What is the difference between FDBIX and IGIB?
Which is cheaper, FDBIX or IGIB?
Should I own both FDBIX and IGIB?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.